Effect of Cognitive Behavior Intervention on Violent Behavior in Female Patients with Schizophrenia

We aimed to explore the effect of cognitive behavior intervention on violent behavior in female patients with schizophrenia (SP). A total of 86 female SP patients who were treated in Fuyang Third People's Hospital from January 2021 to January 2023 were included, and they were randomly divided into control and cognitive behavior intervention groups (n = 43). Patients in the control group received routine psychiatric nursing measures, including basic nursing, drug guidance, safety management, and psychological nursing. Those in the cognitive behavior intervention group received cognitive behavioral intervention based on routine nursing measures, including evaluating the condition and establishing a treatment alliance in the first week, knowledge training in the second week, cognitive reconstruction in the third week, and cognitive behavior training in the fourth week. The number of violent incidents after intervention was compared between the two groups. The Brief Psychiatric Rating Scale (BPRS) was used to compare the nursing effects. The incidence of violent behavior after nursing in the cognitive behavior intervention group was 13.9% (6/43), which was lower than that in the control group (39.5%, 17/43). There was no significant difference in BPRS between the two groups before nursing intervention (p > 0.05). After intervention, BPRS was notably decreased in the two groups than before intervention (p < 0.05), and the BPRS factor scores in the cognitive behavior intervention group were significantly lower than those in the control group (p < 0.05). This study provides preliminary evidence that CBI may reduce the incidence of violent behaviors in female patients with schizophrenia, with the intervention group demonstrating a lower rate of violent incidents compared to the control group. While these findings suggest the potential clinical utility of CBI for managing violence risk in this population, several important limitations must be acknowledged, including the restricted sample size and the exclusion of male patients.